AVH 7.33% $2.53 avita medical inc.

The lack of market penetration at such a bargain price has...

  1. 9,218 Posts.
    lightbulb Created with Sketch. 822
    The lack of market penetration at such a bargain price has always been a problem and even with new management it didn't take off. The reasons have never made sense.
    Odd circumstance and they don't have much ability to up the price in markets they are already in you would think.
    Please keep us up to date as it is very odd .
    It has to come up as a direct question in all future conference calls as to differential pricing, expiry dates, usage etc, Brokers have heard all teh excuses before and never set it out clearly and many optimists have been burned over the years.
    Last edited by Teddyward: 4365 05/10/18
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.